![Jan van Heek](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jan van Heek
Director/Board Member at
MINERVA NEUROSCIENCES, INC.
Net worth: 11 592 $ as of 2026-08-30
Profile
Jan G.
van Heek is the founder of Bio Point Group LLC, founded in 2009, where the title held is Partner & Principal.
The current job is Independent Director at Minerva Neurosciences, Inc. since 2014.
Former jobs include Chairman at BioVex, Inc. from 2007 to 2009; Chairman at BioVex Group, Inc.; Independent Non-Executive Director at Amarin Corp.
Plc from 2010 to 2023; Director at ViaCell, Inc. from 2002 to 2007; Director at Azelon Pharmaceuticals, Inc. from 2004 to 2008; Director-Supervisory Board at PanGenetics BV from 2006 to 2010; Director-Supervisory Board at to-BBB technologies BV; Principal at Baxter Healthcare Corp.; Executive Vice President at Genzyme Corp.; Executive Vice President at Genzyme Ltd; and Member-Supervisory Board at to-BBB Holding BV.
Education includes undergraduate studies at Stanford University and an MBA from the University of St. Gallen.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-02 | 2,542 ( 0.01% ) | 11 592 $ | 2026-08-30 |
Jan van Heek active positions
| Companies | Position | Start |
|---|---|---|
| MINERVA NEUROSCIENCES, INC. | Director/Board Member | 2014-06-30 |
Bio Point Group LLC | Founder | 2008-12-31 |
Former positions of Jan van Heek
| Companies | Position | End |
|---|---|---|
| AMARIN CORPORATION PLC | Director/Board Member | 2023-03-05 |
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Chairman | 2013-01-23 |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Chairman | 2008-12-31 |
Azelon Pharmaceuticals, Inc.
 Azelon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures biopharmaceutical drugs for the treatment of osteoporosis | Director/Board Member | - |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology Provides and develops cellular medicine for the treatment of diseases | Director/Board Member | 2007-11-15 |
Training of Jan van Heek
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
70
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Health Technology |
Amarin Corp. Plc
 Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology Provides and develops cellular medicine for the treatment of diseases | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Azelon Pharmaceuticals, Inc.
Azelon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures biopharmaceutical drugs for the treatment of osteoporosis | Commercial Services |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Health Technology |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genzyme Ltd
 Genzyme Ltd Medical SpecialtiesHealth Technology Biological health care products | Health Technology |
PanGenetics BV
 PanGenetics BV Miscellaneous Commercial ServicesCommercial Services Researches and develops antibody-based therapeutic products | Commercial Services |
University of St. Gallen
 University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
to-BBB Holding BV
 to-BBB Holding BV Pharmaceuticals: GenericHealth Technology Operates as a holding company with interests in providing central nervous system drug technology to the pharmaceutical and biotechnology industries | Health Technology |
to-BBB technologies BV
 to-BBB technologies BV Pharmaceuticals: MajorHealth Technology Develops medicines for brain disease treatment | Health Technology |
Bio Point Group LLC | |
Minerva Neurosciences, Inc.
 Minerva Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes drugs to treat patients suffering from central nervous system diseases | Health Technology |
- Stock Market
- Insiders
- Jan van Heek
